1587 - Clinical Utility of a Cytomegalovirus (CMV)-specific T Cell Assay in Assessing the Risk of Post-Prophylaxis CMV Infection and Post-Treatment Relapse

Friday, October 21, 2022

3:15 PM – 3:30 PM US ET

Location: 144 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Eric Bhaimia, D.O.

Faculty
Rush University Medical Center
Rochester, MN, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Slides

Co-Author(s)

Zachary A. Yetmar, MD

Fellow
Mayo Clinic
Rochester, Minnesota, United States

Disclosure: Disclosure(s): No financial relationships to disclose
VD

Veronica Dioverti, MD

Johns Hopkins
Baltimore, Maryland, United States

Disclosure: Disclosure(s): No financial relationships to disclose
DM

Dante P. Melendez, MD

University of Utah
Salt Lake City, Utah, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Elitza Theel, PhD, D(ABMM)

Director, Infectious Diseases Serology Laboratory
Mayo Clinic
Rochester, Minnesota, United States

Disclosure: Disclosure(s): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()
Raymund R. Razonable, MD

Professor of Medicine
Mayo Clinic
Rochester, Minnesota, United States

Disclosure: Disclosure(s): American Society of Transplantation: Board Member (); gilead: Grant/Research Support (); novartis: DSMB (); regeneron: Grant/Research Support (); Roche: Grant/Research Support ()

Disclosure(s):

Eric Bhaimia, D.O.: No financial relationships to disclose

Zachary A. Yetmar, MD: No financial relationships to disclose

Veronica Dioverti, MD: No financial relationships to disclose

Dante P. Melendez, MD: No financial relationships to disclose

Elitza Theel, PhD, D(ABMM): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Raymund R. Razonable, MD: American Society of Transplantation: Board Member (); gilead: Grant/Research Support (); novartis: DSMB (); regeneron: Grant/Research Support (); Roche: Grant/Research Support ()